KN-510

N/A

Report date: 2026/04/14 20:00:15
NME

Base Information

Drug NameKN-510
Drug Alias NameKN-510KN510
ClassificationSmall molecules
Mechanisms of ActionMitochondrial carnitine/acylcarnitine carrier protein blockers
TargetsMitochondrial carnitine/acylcarnitine carrier protein
Therapy Area/IndicationsSolid tumoursCarcinoma, Pancreatic Ductal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNew Cancer Cure-Bio Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Pancreatic Ductal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A